ContractProduct Rights Agreement • May 18th, 2023 • Alimera Sciences Inc • Pharmaceutical preparations • Georgia
Contract Type FiledMay 18th, 2023 Company Industry JurisdictionCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
PRODUCT RIGHTS AGREEMENT between EyePoint Pharmaceuticals, Inc. and Alimera Sciences, Inc. May 17, 2023Product Rights Agreement • May 18th, 2023 • EyePoint Pharmaceuticals, Inc. • Laboratory analytical instruments • Georgia
Contract Type FiledMay 18th, 2023 Company Industry JurisdictionThis Product Rights Agreement (this “Agreement”) is made as of May 17, 2023 (the “Effective Date”), by and between EyePoint Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 480 Pleasant Street, Suite C-400, Watertown, MA 02472 (“EyePoint”), and Alimera Sciences, Inc., a Delaware corporation with its principal place of business at 6310 Town Square, Suite 400, Alpharetta, GA 30005 (“Alimera”). EyePoint and Alimera are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”